-
Abstract Number: 1319
Impact of ACL Injury Management on the Development of Knee Osteoarthritis: A Meta-analysis
-
Abstract Number: 1320
Individual Socio-economic Status and Symptomatic Hip and Knee Osteoarthritis: A Longitudinal Study, Results from the KHOALA Cohort
-
Abstract Number: 1321
What Is the Relationship Between the 3 Knee Bones in Osteoarthritis? Baseline and Longitudinal Associations Using a Latent Growth Modelling Approach on 37,583 MR Images from the Osteoarthritis Initiative
-
Abstract Number: 1322
Evaluation of Intra-articular CNTX-4975 in Subjects with Painful Bilateral Knee Osteoarthritis: Effects on Pain with Walking and Patient Impression of Change in Pain
-
Abstract Number: 1323
Autologous Conditioned Serum and Plasma Rich in Growth Factors Show Stronger Evidence of Efficacy Than Other Kinds of Platelet-Rich Plasma
-
Abstract Number: 1324
Visceral Fat Deposition Associated with Pain in Osteoarthritis
-
Abstract Number: 1325
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Japanese Subjects of the ADAMTS-5 Inhibitor S201086/GLPG1972, a Potential New Treatment in OA
-
Abstract Number: 1326
Safety Profile to Date of the Novel, Intra-articular Agent Lorecivivint (LOR; SM04690), a CLK/DYRK1A Inhibitor That Modulates the Wnt Pathway, in Subjects with Knee Osteoarthritis
-
Abstract Number: 1327
The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR; SM04690), Which Modulates the Wnt Pathway, Improved Responder Outcomes in Subjects with Knee Osteoarthritis: A Post Hoc Analysis from a Phase 2b Trial
-
Abstract Number: 1328
The Patient’s Perspective on a Disease Flare During Tapering of DMARDs in Rheumatoid Arthritis
-
Abstract Number: 1329
Pooled Safety Analyses from Phase 3 Studies of Filgotinib in Patients with Rheumatoid Arthritis
-
Abstract Number: 1330
No Difference in Treatment Continuation of Different Biologics in Elderly Patients > 70 Years Compared to Younger Patients ≤ 65 Years
-
Abstract Number: 1331
No Confirmation of Increased Risk of Idiopathic Facial Nerve Palsy Under Tocilizumab
-
Abstract Number: 1332
United States Rheumatology Practice-Based Real-World Evidence of Infusion Reactions in Rheumatoid Arthritis Patients Treated with Intravenous Golimumab or Infliximab: Impact of Prior Biologic Exposure and Methotrexate Utilization
-
Abstract Number: 1333
The Comparative Risk of Osteoporotic Fractures Among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Nation-wide Cohort Study in Korea
- « Previous Page
- 1
- …
- 89
- 90
- 91
- 92
- 93
- …
- 198
- Next Page »